Insiders Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 08:28:14 2025-07-15 EDT			5-day change	1st Jan Change
443.85 ^DKK	+0.14%		-1.01%	-28.64%

07:33am	Kailera touts late-stage win for weight-loss drug in China	RE
05:22am	Indutrade: Life Science Achieved Positive Organic Growth Excluding Novo Nordisk Sales	FW

Insiders

Activist Hedge Fund Parvus Builds Stake in Novo Nordisk, FT Reports, Citing Sources	06-10	DJ
Activist hedge fund Parvus builds stake in Novo Nordisk, FT reports	06-09	RE
Activist hedge fund Parvus builds stake in Novo Nordisk, FT reports	06-09	RE
Activist Hedge Fund Parvus Asset Management Builds Stake In Ozempic-Maker Novo Nordisk- FT	06-09	RE
AlphaValue/Baader Europe Cuts Novo Nordisk Price Target, Earnings Forecasts on Rising Competition	06-09	MT
Parvus Asset Management Provides Information to Shareholders of Novo Nordisk	06-09	CI
Novo Nordisk's Next CEO Said Likely an Outsider	05-22	MT
Novo Nordisk's former chief makes comeback to steer choice of new CEO	05-22	RE
AlphaValue/Baader Europe Notes 'Surprise' Novo Nordisk CEO Change	05-20	MT
Zealand Pharma A/S Appoints Steven Johnson as Chief Development Officer	05-19	CI
Novo Nordisk should look to the US for its next CEO, analysts say	05-16	RE
Novo Nordisk ousts CEO after falling behind in weight loss market	05-16	RE
From insulin to Ozempic, history of Novo Nordisk's CEOs	05-16	RE
Novo Nordisk ousts CEO after falling behind in weight loss market	05-16	RE
Novo Nordisk CEO's surprise exit after setbacks in weight-loss market	05-16	RE
INSTANT VIEW-Novo Nordisk CEO's surprise exit after setbacks in weight-loss market	05-16	RE
Novo Nordisk CEO to Step Down Amid Market Challenges	05-16	MT
Novo Ousts CEO Jorgensen Over Competition, Share Price	05-16	MT
Novo Nordisk's CEO to Leave	05-16	MT
Talks to replace Novo Nordisk CEO lasted several weeks, board chair says	05-16	RE
Talks to replace Novo Nordisk CEO lasted several weeks, board chair says	05-16	RE
Novo Nordisk CEO to Step Down as Market Challenges Mount -- 2nd Update	05-16	DJ
Discussions to replace Novo Nordisk CEO have been ongoing for weeks, board chair says	05-16	RE